Page last updated: 2024-12-06

heptacaine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

heptacaine: structure; RN given refers to the HCl salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID41610
MeSH IDM0061377

Synonyms (11)

Synonym
piperidinoethyl 2-heptoxyphenylcarbamoate hydrochloride
n-(2-(heptyloxyphenylcarbamoyloxy)ethyl)piperidinium chloride
ccris 3897
(2-(heptyloxy)phenyl)carbamic acid 2-(1-piperidinyl)ethyl ester hydrochloride
n-2-(2-heptyloxyphenylcarbamoyloxy)ethylpiperidinium chloride
2-heptyloxycarbanilic acid 2-(1-piperidinyl)ethyl ester hydrochloride
carbamic acid, (2-(heptyloxy)phenyl)-, 2-(1-piperidinyl)ethyl ester, monohydrochloride
heptacaine
55792-21-7
[2-(2-heptyloxyphenylcarbamoyloxy)-ethyl]-piperidinium chloride
2-piperidin-1-ium-1-ylethyl n-(2-heptoxyphenyl)carbamate;chloride

Research Excerpts

Pharmacokinetics

ExcerptReferenceRelevance
" The plasma elimination half-life of heptacaine was 133 min and its biological availability of 52% was comparable to other agents of the class."( Pharmacokinetics of heptacaine, a novel potent local anaesthetic agent, after rectal administration to rats.
Divisová, D; Durisová, M; Faberová, V; Trnovec, T,
)
0.73
" An open two-compartment pharmacokinetic model was conferred to the data."( Pharmacokinetics of the new local anaesthetic N-[2-(2-Heptyloxyphenylcarbamoyloxy)ethyl]piperidinium chloride in rats and mice.
Bezek, S; Durisovă, M; Kállay, Z; Scasnár, V; Trnovec, T, 1987
)
0.27

Dosage Studied

ExcerptRelevanceReference
" Linking up with the previous studies, the paper investigated the effects of two auxiliary substances--cellulose derivatives (hydroxyethylcellulose, methylcellulose)--and their concentration on the pharmaceutical availability of the potential drug XX B from the dosage form."( [Effect of macromolecular substances on pharmaceutical availability of a potential local anesthetic].
Svehlová, E, 2000
)
0.31
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (62)

TimeframeStudies, This Drug (%)All Drugs %
pre-199036 (58.06)18.7374
1990's13 (20.97)18.2507
2000's10 (16.13)29.6817
2010's3 (4.84)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 9.92

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index9.92 (24.57)
Research Supply Index4.17 (2.92)
Research Growth Index4.10 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (9.92)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other63 (98.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]